Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services. The ...
Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...
Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to SOTIO Biotech, a ...
Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its ...
Oxford, UK and San Jose, California, 9 January 2024 - (OBT), a clinical stage oncology company with a pipeline of ...
We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...
After inking a series of partnerships late last year, Lonza’s antibody-drug conjugate (ADC) specialist Synaffix is kicking ...
Ingelheim, Germany Thursday, January 9, 2025, 15:00 Hrs [IST] ...
Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.
The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...